22.14  0.405 (1.86%)		11-28 12:14
Open: 21.87 High: 22.14 Volume: 1,541		Pre. Close: 21.735 Low: 21.87 Market Cap: 109(M)

Short term
Mid term
Targets	6-month :	25.85	1-year :	30.2
Resists	First :	22.13	Second :	25.85
Pivot price	21.22
Supports	First :	19.76	Second :	18.29
MAs	MA(5) :	21.79	MA(20) :	20.88
	MA(100) :	21.63	MA(250) :	22.28
MACD	MACD :	0.4	Signal :	0.2
%K %D	K(14,3) :	91.6	D(3) :	91.6
RSI	RSI(14): 65.4
52-week	High :	25.15	Low :	18.29

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ KF ] has closed below upper band by 7.7%. Bollinger Bands are 7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	21.89 - 22	22 - 22.09
Low:	21.24 - 21.37	21.37 - 21.47
Close:	21.55 - 21.74	21.74 - 21.91

The Korea Fund, Inc. is a closed-ended equity mutual fund launched and managed by Allianz Global Investors U.S. LLC. The fund invests in the public equity markets of Korea. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of companies. It employs fundamental analysis with a bottom-up stock picking approach, focusing on such factors as price-to-earnings ratios, dividend yields, and earnings-per-share growth to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI Korea 25/50 Index. It uses 'Grassroots Research' to make its investments. The Korea Fund, Inc. was formed on August 29, 1984 and is domiciled in the United States.

Sat, 21 Oct 2023
Your Weekend Reading: Struggling to Prevent a Regional War - Bloomberg

Wed, 27 Sep 2023
The Korea Fund, Inc. Announces Changes to its Discount ... - Business Wire

Mon, 25 Sep 2023
Baseline gut microbiota and metabolome predict durable ... - Nature.com

Mon, 24 Jul 2023
Cationic-nanogel nasal vaccine containing the ectodomain of RSV ... - Nature.com

Mon, 17 Apr 2023
SGLT2 inhibition ameliorates nano plastics-induced premature ... - Nature.com

Thu, 16 Mar 2023
Crop switching can enhance environmental sustainability and ... - Nature.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NYSE
Sector: Financial Services
Industry: Asset Management
Shares Out	5 (M)
Shares Float	0 (M)
Held by Insiders	6.6 (%)
Held by Institutions	78.6 (%)
Shares Short	1 (K)
Shares Short P.Month	3 (K)

EPS	1.25
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	24.7
Profit Margin	214.4 %
Operating Margin	-92 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	-6.9 %
Gross Profit (p.s.)	0.58
Sales Per Share	0.58
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	17.71
PEG Ratio	0
Price to Book value	0.89
Price to Sales	38.03
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.